We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · June 07, 2021

Prevalence and Predictors of Adverse Events With Methotrexate for RA

Rheumatology (Oxford, England)


Additional Info

Rheumatology (Oxford, England)
Prevalence and Predictors of Adverse Events With Methotrexate Mono- and Combination-Therapy for Rheumatoid Arthritis: A Systematic Review
Rheumatology (Oxford) 2021 Apr 28;[EPub Ahead of Print], AA Sherbini, SD Sharma, JM Gwinnutt, KL Hyrich, SMM Verstappen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading